ainewsblitz.com

Breaking

Formation Bio Names Ex-Biogen R&D Chief Michael Ehlers as Chief Scientific Officer

Formation Bio Names Ex-Biogen R&D Chief Michael Ehlers as Chief Scientific Officer
  • Healthcare
  • Recruiting & HR
  • Funding & M&A

Formation Bio, the AI-focused drug development startup backed by Sam Altman and Sequoia Capital, has appointed former Biogen research chief Michael Ehlers as its chief scientific officer and head of research and development. The July 22 hire brings a decorated pharmaceutical and biotech veteran into a company that has positioned itself as a "pharma of the future," seeking to compress the decade-long, multibillion-dollar timelines of conventional drug development using an AI-native platform.

Continue reading

The rest of this article is for AI News Blitz readers. Choose an option below to keep reading.

$20
Read this article
$29/month
Unlimited — all 27,934 articles, the full archive, and comprehension quizzes
Save 72%
$98/year
≈ $8.17/month
Unlimited, billed once a year